NCT02761369Unknown不适用
Comparison of Two Deep TMS Protocols With Paired Associative Stimulation (PAS) for the Treatment of Food Addiction in Severe Obesity
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Change in weight
研究概览
简要总结
The neurobiological underpinnings of obesity point to brain asymmetry in cortical and deeper brain regions. Furthermore, chemical, structural and functional imbalance in cortical and sub-cortical brain regions alters reward processing, attentional control and self-regulation in food-addicted obese individuals. In this study the investigators use TMS with a special multichannel H-coil developed by their lab to safely stimulate cortical and deeper brain regions in obese humans. The investigators aim to produce interhemispheric neuroplasticity (INP) using a paired associative stimulation (PAS) protocol over the DLPFC, to restore neurobiological functioning, alleviate food addiction symptoms, and promote weight loss.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 22 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •30 ≤ BMI ≥
- •Having had at least one prior conventional weight loss attempt, but no current weight loss attempts or over the last 3 months.
- •Having satisfied a safety screening questionnaire for TMS (Keel, 2001)
- •Omnivorous
- •Have not had experience with TMS of any kind
排除标准
- •The participant experiences tremor in any limb.
- •The participant experiences seizures.
- •The participant has a history of epilepsy or seizure (EXCEPT those therapeutically induced by ECT), or a history of such in first degree relatives.
- •The participant is at increased risk for seizures for any reason, including prior diagnosis of increased intracranial pressure (such as after large infarctions or trauma), or a history of significant head trauma with loss of consciousness for > 5 minutes.
- •The participant has a history of head injury.
- •The participant suffers from an unstable physical disease, such as high blood pressure (>150 mmHg systolic / diastolic > 110 mmHg) or acute, unstable cardiac disease The participant is at a high risk for severe violence or suicidal tendencies, assessed during the screening interview (see appendix 4).
- •The participant has metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neuro-stimulators, intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or implanted medical pumps.
- •The participant is having, or has had, any metal in the head (outside the mouth).
- •The participant suffers from a significant neurological disorder or insult including, but not limited to:
- •Any condition likely to be associated with increased intracranial pressure
- •Space occupying brain lesion
- •History of cerebrovascular accident
- •Transient ischemic attack within the last two years
- •Cerebral aneurysm
- •Parkinson's disease
- •Huntington's chorea
- •Multiple sclerosis
- •The participant has any cognitive or functional disability, according to criteria specified in the DSM-V, such as active psychiatric disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-V; Axis I and Axis II) diagnosed within the last year.
- •The participant has started or changed a psychotropic prescription within the last three months.
- •The participant has current alcohol or other substance abuse or dependence, or has had one over the last 12 months prior to recruitment.
- •The participant can't reliably communicate with the investigator, or is unlikely to cope with the requirements of the experiment.
- •The participant is having a known or suspected pregnancy or lactation.
- •The participant is a sexually-active woman of childbearing age, who does not use a medically accepted form of contraception.
- •The motor threshold can't be found or quantified.
- •The PI decides that the participant should be withdrawn from the study for the safety and welfare of the participant. For example, the participant experiences adverse event which is contraindicated with the continuation in the study.
- •A history of intolerance to a TMS treatment.
- •The participant asks for withdrawal
结局指标
主要结局
Change in weight
时间窗: Change in weight between baseline versus the end of the treatment (day 15) and follow-up (a month after day 15)
Unit of measure: BMI in kg/m\^2 (weight in kilograms, height in meters)
次要结局
- Food addiction symptoms(Change between baseline versus the end of the treatment (day 15) and follow-up (a month after day 15))
- Performance on a food Stroop test(Change in performance between baseline versus the end of the treatment (day 15) and follow-up (a month after day 15))
- Quality of life(Change between baseline and the end of the treatment (day 15) and follow-up (a month after day 15))
- Safety and tolerability of a PAS protocol using the multi-channel deep TMS system, measured via the number of adverse events (AE)(Throughout the study period, estimated as 2 years)
- Eating behavior (cognitive restraint, disinhibition, and hunger)(Change between baseline versus the end of the treatment (day 15) and follow-up (a month after day 15))
- Implementation of INP(Changes in cortical excitability between baseline versus following 15 days of treatment)
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem CellsObesity, MorbidNCT03263390University of California, San Diego6
已完成
不适用
fMRI and Appetite-Related Hormones Pre and Post Obesity SurgeryObesityNCT01583725New York Obesity and Nutrition Research Center120
Unknown
不适用
Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating DisorderBinge Eating DisorderObesityNCT01868204Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente60
尚未招募
不适用
Dysregulation of brain reward systems in obesity: measuring endogenous dopamine levels by acute dopamine depletiofatty degeneration10003018obesityNL-OMON34239Academisch Medisch Centrum30
已完成
不适用
Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor DisabilityCerebrovascular AccidentHealthyNCT00029718National Institute of Neurological Disorders and Stroke (NINDS)57